Table 2.
First Author (Title) | Type of the Review | Aim of the Review | Number and Type of Studies Included | VET Devices |
---|---|---|---|---|
Görlinger et al. [69] (COVID-19 associated coagulopathy and inflammatory response: what do we know already and what are the knowledge gaps?) |
Narrative review | Review of coagulation abnormalities and inflammatory response associated with COVID-19 | 8 studies (5 prospective, 3 retrospective) | ROTEM, TEG, Quantra |
Tsantes et al. [70] (COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness) |
Narrative review | Evaluation of the usefulness of VETs in clinical practice to guide anticoagulant treatments or predict prognosis | 13 studies (8 prospective, 5 retrospective) | ROTEM, TEG, Quantra |
Hartmann et al. [71] (The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review) |
Systematic review | Evaluation of the usefulness of TEG in clinical practice to identify and manage hypercoagulation associated with COVID-19 | 15 studies (5 prospective, 9 retrospective and one case report) | TEG |
Słomka et al. [72] (Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review) |
Systematic review | Evaluation of the performance of TEG and TEM in the assessment of blood coagulation and fibrinolysis in patients with COVID-19 | 10 studies (2 prospective, 8 retrospective) | ROTEM, TEG |